Literature DB >> 33688490

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements.

Ivana Mikolasevic1,2,3, Goran Poropat1,3, Tajana Filipec Kanizaj2,4, Nadija Skenderevic2, Marko Zelic3,5,6, Marija Matasin4, Luka Vranic1,3, Andrea Kresovic1, Goran Hauser1,3,5.   

Abstract

Aim: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD).
Methods: In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD.
Results: The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m2. The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis.
Conclusion: To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables.
Copyright © 2021 Ivana Mikolasevic et al.

Entities:  

Year:  2021        PMID: 33688490      PMCID: PMC7925017          DOI: 10.1155/2021/6670065

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  39 in total

1.  Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.

Authors:  Yang Won Min; Youngha Kim; Geum-Youn Gwak; Seonhye Gu; Danbee Kang; Soo Jin Cho; Eliseo Guallar; Juhee Cho; Dong Hyun Sinn
Journal:  J Gastroenterol Hepatol       Date:  2018-02-15       Impact factor: 4.029

Review 2.  Obesity and GERD.

Authors:  Paul Chang; Frank Friedenberg
Journal:  Gastroenterol Clin North Am       Date:  2013-12-27       Impact factor: 3.806

3.  The association of metabolic syndrome with reflux esophagitis: a case-control study.

Authors:  P Wu; L Ma; G X Dai; Y Chen; Y L Tong; C Wang; L W Yao; Y X Jiang; S C Xu; Z S Ai
Journal:  Neurogastroenterol Motil       Date:  2011-09-13       Impact factor: 3.598

4.  Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan.

Authors:  Masatoshi Niigaki; Kyoichi Adachi; Kazuya Hirakawa; Kenji Furuta; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

Review 5.  GERD and obesity: is the autonomic nervous system the missing link?

Authors:  Neranjani Devendran; Nita Chauhan; David Armstrong; Adrian R M Upton; Markad V Kamath
Journal:  Crit Rev Biomed Eng       Date:  2014

6.  Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.

Authors:  I Mikolasevic; S Racki; V Lukenda; M Pavletic-Persic; S Milic; L Orlic
Journal:  Med Hypotheses       Date:  2013-11-09       Impact factor: 1.538

Review 7.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.

Authors:  Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo; Christopher P Day
Journal:  Obesity (Silver Spring)       Date:  2008-03-27       Impact factor: 5.002

Review 9.  Nonalcoholic fatty liver disease - A multisystem disease?

Authors:  Ivana Mikolasevic; Sandra Milic; Tamara Turk Wensveen; Ivana Grgic; Ivan Jakopcic; Davor Stimac; Felix Wensveen; Lidija Orlic
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

Review 10.  Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

Authors:  Ivana Mikolasevic; Tajana Filipec-Kanizaj; Maja Mijic; Ivan Jakopcic; Sandra Milic; Irena Hrstic; Nikola Sobocan; Davor Stimac; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

View more
  1 in total

1.  The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.

Authors:  Yoo Min Han; Jooyoung Lee; Ji Min Choi; Min-Sun Kwak; Jong In Yang; Su Jin Chung; Jeong Yoon Yim; Goh Eun Chung
Journal:  PLoS One       Date:  2021-12-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.